fanta.bio Sample: CNhs11854
17556 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1311 / 15404 (8.5%) | 349 / 154040 (0.2%) | −324.0 | −324.0 | 37.56 |
| TP53 SRX19538268 | U2OS Bone | 489 / 15404 (3.2%) | 140 / 154040 (0.1%) | −324.0 | −324.0 | 34.93 |
| TP53 SRX19538267 | U2OS Bone | 432 / 15404 (2.8%) | 131 / 154040 (0.1%) | −324.0 | −324.0 | 32.98 |
| TP53 SRX19538276 | U2OS Bone | 481 / 15404 (3.1%) | 149 / 154040 (0.1%) | −324.0 | −324.0 | 32.28 |
| TP53 SRX19538274 | U2OS Bone | 483 / 15404 (3.1%) | 154 / 154040 (0.1%) | −324.0 | −324.0 | 31.36 |
| TP53 SRX19538275 | U2OS Bone | 439 / 15404 (2.8%) | 140 / 154040 (0.1%) | −324.0 | −324.0 | 31.36 |
| HIF1A SRX11007095 | HK-2 Kidney | 2427 / 15404 (15.8%) | 809 / 154040 (0.5%) | −324.0 | −324.0 | 30.00 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 529 / 15404 (3.4%) | 178 / 154040 (0.1%) | −324.0 | −324.0 | 29.72 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1872 / 15404 (12.2%) | 640 / 154040 (0.4%) | −324.0 | −324.0 | 29.25 |
| TP53 SRX19538280 | Osteoblasts Bone | 465 / 15404 (3.0%) | 166 / 154040 (0.1%) | −324.0 | −324.0 | 28.01 |
| SCML2 SRX644728 | 293 Kidney | 1583 / 15404 (10.3%) | 624 / 154040 (0.4%) | −324.0 | −324.0 | 25.37 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1779 / 15404 (11.5%) | 703 / 154040 (0.5%) | −324.0 | −324.0 | 25.31 |
| TP53 SRX19538279 | Osteoblasts Bone | 592 / 15404 (3.8%) | 234 / 154040 (0.2%) | −324.0 | −324.0 | 25.30 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 2472 / 15404 (16.0%) | 1055 / 154040 (0.7%) | −324.0 | −324.0 | 23.43 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 2397 / 15404 (15.6%) | 1043 / 154040 (0.7%) | −324.0 | −324.0 | 22.98 |
| HIF1A SRX20663235 | HK-2 Kidney | 516 / 15404 (3.3%) | 246 / 154040 (0.2%) | −324.0 | −324.0 | 20.98 |
| FOXP1 SRX736067 | LNCAP Prostate | 1902 / 15404 (12.3%) | 1055 / 154040 (0.7%) | −324.0 | −324.0 | 18.03 |
| MYH11 SRX265221 | ME-1 Blood | 895 / 15404 (5.8%) | 547 / 154040 (0.4%) | −324.0 | −324.0 | 16.36 |
| BRD4 SRX9419935 | BT-474 Breast | 3555 / 15404 (23.1%) | 2583 / 154040 (1.7%) | −324.0 | −324.0 | 13.76 |
| BRD4 SRX9419937 | BT-474 Breast | 3579 / 15404 (23.2%) | 2618 / 154040 (1.7%) | −324.0 | −324.0 | 13.67 |
| MED1 SRX9419944 | BT-474 Breast | 3480 / 15404 (22.6%) | 2548 / 154040 (1.7%) | −324.0 | −324.0 | 13.66 |
| MED1 SRX9419945 | BT-474 Breast | 3538 / 15404 (23.0%) | 2598 / 154040 (1.7%) | −324.0 | −324.0 | 13.62 |
| MED1 SRX9419947 | BT-474 Breast | 3509 / 15404 (22.8%) | 2672 / 154040 (1.7%) | −324.0 | −324.0 | 13.13 |
| MED1 SRX9419946 | BT-474 Breast | 3602 / 15404 (23.4%) | 2743 / 154040 (1.8%) | −324.0 | −324.0 | 13.13 |
| BRD4 SRX9419938 | BT-474 Breast | 3560 / 15404 (23.1%) | 2736 / 154040 (1.8%) | −324.0 | −324.0 | 13.01 |
| BRD4 SRX9419936 | BT-474 Breast | 3606 / 15404 (23.4%) | 2774 / 154040 (1.8%) | −324.0 | −324.0 | 13.00 |
| EZH2 SRX2146136 | LNCAP Prostate | 7631 / 15404 (49.5%) | 7536 / 154040 (4.9%) | −324.0 | −324.0 | 10.13 |
| BRD4 SRX736201 | 90-8TL Neural | 6001 / 15404 (39.0%) | 6091 / 154040 (4.0%) | −324.0 | −324.0 | 9.85 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 761 / 15404 (4.9%) | 846 / 154040 (0.5%) | −324.0 | −324.0 | 9.00 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1902 / 15404 (12.3%) | 2478 / 154040 (1.6%) | −324.0 | −324.0 | 7.68 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1442 / 15404 (9.4%) | 3394 / 154040 (2.2%) | −324.0 | −324.0 | 4.25 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1597 / 15404 (10.4%) | 4742 / 154040 (3.1%) | −324.0 | −324.0 | 3.37 |
| PBX4 SRX2731658 | PC-3 Prostate | 648 / 15404 (4.2%) | 24312 / 154040 (15.8%) | −324.0 | −324.0 | 0.27 |
| YAP1 SRX757325 | H2052 Lung | 485 / 15404 (3.1%) | 18736 / 154040 (12.2%) | −324.0 | −324.0 | 0.26 |
| FOS SRX150477 | MCF 10A Breast | 434 / 15404 (2.8%) | 17955 / 154040 (11.7%) | −324.0 | −324.0 | 0.24 |
| TP53 SRX19538281 | Osteoblasts Bone | 495 / 15404 (3.2%) | 252 / 154040 (0.2%) | −322.8 | −319.9 | 19.64 |
| FOS SRX150478 | MCF 10A Breast | 473 / 15404 (3.1%) | 18429 / 154040 (12.0%) | −322.6 | −319.7 | 0.26 |
| TP53 SRX19538273 | U2OS Bone | 424 / 15404 (2.8%) | 136 / 154040 (0.1%) | −315.9 | −313.0 | 31.18 |
| TP53 SRX19538269 | U2OS Bone | 525 / 15404 (3.4%) | 362 / 154040 (0.2%) | −305.9 | −302.9 | 14.50 |
| AGO2 SRX4708039 | Hep G2 Liver | 1911 / 15404 (12.4%) | 6844 / 154040 (4.4%) | −300.8 | −297.9 | 2.79 |
| YAP1 SRX757326 | H2052 Lung | 416 / 15404 (2.7%) | 16737 / 154040 (10.9%) | −298.9 | −296.0 | 0.25 |
| IRF3 SRX11453858 | Hep G2 Liver | 354 / 15404 (2.3%) | 64 / 154040 (0.0%) | −296.4 | −293.5 | 55.31 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 464 / 15404 (3.0%) | 17258 / 154040 (11.2%) | −288.2 | −285.3 | 0.27 |
| TP53 SRX19538270 | U2OS Bone | 496 / 15404 (3.2%) | 358 / 154040 (0.2%) | −283.4 | −280.5 | 13.85 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 668 / 15404 (4.3%) | 872 / 154040 (0.6%) | −280.1 | −277.2 | 7.66 |
| FOS SRX4192880 | MCF 10A Breast | 328 / 15404 (2.1%) | 14556 / 154040 (9.4%) | −278.4 | −275.6 | 0.23 |
| FOXA1 SRX4815198 | MCF-7 Breast | 830 / 15404 (5.4%) | 22202 / 154040 (14.4%) | −260.9 | −258.0 | 0.37 |
| Epitope tags SRX10549776 | K-562 Blood | 1453 / 15404 (9.4%) | 4758 / 154040 (3.1%) | −257.4 | −254.6 | 3.05 |
| AR SRX10820653 | LNCAP Prostate | 378 / 15404 (2.5%) | 169 / 154040 (0.1%) | −256.9 | −254.0 | 22.37 |
| TP53 SRX19538282 | Osteoblasts Bone | 427 / 15404 (2.8%) | 275 / 154040 (0.2%) | −255.5 | −252.7 | 15.53 |
| FOS SRX150517 | MCF 10A Breast | 368 / 15404 (2.4%) | 14551 / 154040 (9.4%) | −253.5 | −250.7 | 0.25 |
| IRF3 SRX11453861 | Hep G2 Liver | 311 / 15404 (2.0%) | 73 / 154040 (0.0%) | −248.2 | −245.4 | 42.60 |
| JUNB SRX8488088 | SUM 229PE Breast | 443 / 15404 (2.9%) | 15614 / 154040 (10.1%) | −245.9 | −243.1 | 0.28 |
| FOXA1 SRX4815197 | MCF-7 Breast | 604 / 15404 (3.9%) | 18215 / 154040 (11.8%) | −245.0 | −242.2 | 0.33 |
| FOS SRX150476 | MCF 10A Breast | 388 / 15404 (2.5%) | 14619 / 154040 (9.5%) | −244.1 | −241.3 | 0.27 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 871 / 15404 (5.7%) | 22232 / 154040 (14.4%) | −244.0 | −241.2 | 0.39 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 629 / 15404 (4.1%) | 938 / 154040 (0.6%) | −240.8 | −238.1 | 6.71 |
| BRD4 SRX736204 | 90-8TL Neural | 1009 / 15404 (6.6%) | 2601 / 154040 (1.7%) | −238.7 | −235.9 | 3.88 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 890 / 15404 (5.8%) | 22076 / 154040 (14.3%) | −231.7 | −229.0 | 0.40 |
| FOXA1 SRX176862 | MCF-7 Breast | 308 / 15404 (2.0%) | 12818 / 154040 (8.3%) | −231.4 | −228.7 | 0.24 |
| KAT6A SRX20971022 | Fibroblasts Others | 291 / 15404 (1.9%) | 70 / 154040 (0.0%) | −231.1 | −228.4 | 41.57 |
| TP53 SRX19538271 | U2OS Bone | 664 / 15404 (4.3%) | 1129 / 154040 (0.7%) | −230.6 | −227.8 | 5.88 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 608 / 15404 (3.9%) | 17746 / 154040 (11.5%) | −228.9 | −226.2 | 0.34 |
| FOXA1 SRX176863 | MCF-7 Breast | 282 / 15404 (1.8%) | 12200 / 154040 (7.9%) | −226.6 | −223.9 | 0.23 |
| ESR1 SRX371478 | MCF-7 Breast | 307 / 15404 (2.0%) | 12584 / 154040 (8.2%) | −224.2 | −221.5 | 0.24 |
| AR SRX1067071 | LHSAR Prostate | 501 / 15404 (3.3%) | 15840 / 154040 (10.3%) | −222.5 | −219.8 | 0.32 |
| JUN SRX17561461 | LPS141 Adipocyte | 344 / 15404 (2.2%) | 13186 / 154040 (8.6%) | −222.1 | −219.5 | 0.26 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 294 / 15404 (1.9%) | 12259 / 154040 (8.0%) | −221.1 | −218.4 | 0.24 |
| AR SRX10820651 | LNCAP Prostate | 382 / 15404 (2.5%) | 269 / 154040 (0.2%) | −220.4 | −217.7 | 14.20 |
| GATA3 SRX190239 | MCF-7 Breast | 369 / 15404 (2.4%) | 13503 / 154040 (8.8%) | −218.3 | −215.7 | 0.27 |
| FOS SRX4192879 | MCF 10A Breast | 255 / 15404 (1.7%) | 11448 / 154040 (7.4%) | −218.1 | −215.5 | 0.22 |
| JUNB SRX8488073 | SUM 229PE Breast | 478 / 15404 (3.1%) | 15321 / 154040 (9.9%) | −218.1 | −215.4 | 0.31 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 274 / 15404 (1.8%) | 11759 / 154040 (7.6%) | −216.7 | −214.0 | 0.23 |
| YAP1 SRX5718140 | 293 Kidney | 439 / 15404 (2.8%) | 14584 / 154040 (9.5%) | −215.0 | −212.3 | 0.30 |
| FOXA1 SRX3931044 | MCF-7 Breast | 575 / 15404 (3.7%) | 16753 / 154040 (10.9%) | −214.5 | −211.9 | 0.34 |
| ESR1 SRX7624157 | MCF-7 Breast | 702 / 15404 (4.6%) | 18697 / 154040 (12.1%) | −214.4 | −211.8 | 0.38 |
| ESR1 SRX20282961 | MCF-7 Breast | 309 / 15404 (2.0%) | 12314 / 154040 (8.0%) | −214.0 | −211.4 | 0.25 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 282 / 15404 (1.8%) | 11828 / 154040 (7.7%) | −213.9 | −211.3 | 0.24 |
| FOXA1 SRX371482 | MCF-7 Breast | 371 / 15404 (2.4%) | 13390 / 154040 (8.7%) | −213.6 | −211.0 | 0.28 |
| RUNX1 SRX2513054 | 293 Kidney | 3030 / 15404 (19.7%) | 16374 / 154040 (10.6%) | −212.8 | −210.2 | 1.85 |
| GATA3 SRX190194 | SK-N-SH Neural | 637 / 15404 (4.1%) | 17630 / 154040 (11.4%) | −212.1 | −209.5 | 0.36 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 2006 / 15404 (13.0%) | 8976 / 154040 (5.8%) | −212.0 | −209.4 | 2.23 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 890 / 15404 (5.8%) | 21342 / 154040 (13.9%) | −211.4 | −208.8 | 0.42 |
| ESR1 SRX4367193 | MCF-7 Breast | 908 / 15404 (5.9%) | 21586 / 154040 (14.0%) | −211.0 | −208.4 | 0.42 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 567 / 15404 (3.7%) | 16486 / 154040 (10.7%) | −210.2 | −207.6 | 0.34 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 168 / 15404 (1.1%) | 9509 / 154040 (6.2%) | −209.9 | −207.3 | 0.18 |
| RELA SRX2207673 | HUVEC Cardiovascular | 1026 / 15404 (6.7%) | 23184 / 154040 (15.1%) | −209.3 | −206.7 | 0.44 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 232 / 15404 (1.5%) | 10754 / 154040 (7.0%) | −209.2 | −206.6 | 0.22 |
| AR SRX1067070 | LHSAR Prostate | 677 / 15404 (4.4%) | 18124 / 154040 (11.8%) | −208.8 | −206.2 | 0.37 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 666 / 15404 (4.3%) | 17954 / 154040 (11.7%) | −208.6 | −206.0 | 0.37 |
| FOXA1 SRX1161177 | MCF-7 Breast | 247 / 15404 (1.6%) | 10984 / 154040 (7.1%) | −207.3 | −204.7 | 0.22 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 455 / 15404 (3.0%) | 14596 / 154040 (9.5%) | −207.2 | −204.7 | 0.31 |
| KAT7 SRX101303 | RKO Digestive tract | 1330 / 15404 (8.6%) | 4747 / 154040 (3.1%) | −206.3 | −203.8 | 2.80 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 337 / 15404 (2.2%) | 12491 / 154040 (8.1%) | −203.5 | −200.9 | 0.27 |
| FOXA1 SRX371483 | MCF-7 Breast | 289 / 15404 (1.9%) | 11635 / 154040 (7.6%) | −203.3 | −200.8 | 0.25 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 375 / 15404 (2.4%) | 13133 / 154040 (8.5%) | −203.1 | −200.6 | 0.29 |
| AGO2 SRX6783957 | Hep G2 Liver | 1224 / 15404 (7.9%) | 4175 / 154040 (2.7%) | −202.8 | −200.3 | 2.93 |
| FOXA1 SRX371481 | MCF-7 Breast | 272 / 15404 (1.8%) | 11310 / 154040 (7.3%) | −202.7 | −200.1 | 0.24 |
| 5-mC SRX882970 | LNCAP Prostate | 2676 / 15404 (17.4%) | 13975 / 154040 (9.1%) | −202.6 | −200.1 | 1.91 |
| BRD1 SRX286203 | RKO Digestive tract | 1163 / 15404 (7.5%) | 3829 / 154040 (2.5%) | −202.6 | −200.1 | 3.04 |
| BMI1 SRX644729 | 293 Kidney | 287 / 15404 (1.9%) | 113 / 154040 (0.1%) | −202.5 | −199.9 | 25.40 |
| RELA SRX2207672 | HUVEC Cardiovascular | 1127 / 15404 (7.3%) | 24307 / 154040 (15.8%) | −202.2 | −199.7 | 0.46 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 658 / 15404 (4.3%) | 17590 / 154040 (11.4%) | −201.7 | −199.2 | 0.37 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 459 / 15404 (3.0%) | 14475 / 154040 (9.4%) | −201.5 | −199.0 | 0.32 |
| TCF12 SRX190356 | SK-N-SH Neural | 771 / 15404 (5.0%) | 19259 / 154040 (12.5%) | −201.4 | −198.9 | 0.40 |
| SMARCA4 SRX5212366 | Mel270 Others | 342 / 15404 (2.2%) | 12506 / 154040 (8.1%) | −201.1 | −198.7 | 0.27 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 525 / 15404 (3.4%) | 15516 / 154040 (10.1%) | −201.0 | −198.5 | 0.34 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 820 / 15404 (5.3%) | 2038 / 154040 (1.3%) | −201.0 | −198.5 | 4.02 |
| ESR1 SRX371469 | MCF-7 Breast | 262 / 15404 (1.7%) | 11066 / 154040 (7.2%) | −200.7 | −198.3 | 0.24 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 533 / 15404 (3.5%) | 15628 / 154040 (10.1%) | −200.6 | −198.1 | 0.34 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 526 / 15404 (3.4%) | 15515 / 154040 (10.1%) | −200.4 | −198.0 | 0.34 |
| AGO2 SRX6783958 | Hep G2 Liver | 1200 / 15404 (7.8%) | 4067 / 154040 (2.6%) | −200.4 | −197.9 | 2.95 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 281 / 15404 (1.8%) | 107 / 154040 (0.1%) | −200.1 | −197.6 | 26.26 |
| JUN SRX4192884 | MCF 10A Breast | 177 / 15404 (1.1%) | 9412 / 154040 (6.1%) | −199.8 | −197.4 | 0.19 |
| ESR1 SRX371479 | MCF-7 Breast | 230 / 15404 (1.5%) | 10444 / 154040 (6.8%) | −199.8 | −197.3 | 0.22 |
| BRPF3 SRX796085 | RKO Digestive tract | 1064 / 15404 (6.9%) | 3328 / 154040 (2.2%) | −198.5 | −196.1 | 3.20 |
| ESR1 SRX176860 | MCF-7 Breast | 449 / 15404 (2.9%) | 14213 / 154040 (9.2%) | −198.5 | −196.0 | 0.32 |
| CEBPB SRX150632 | HeLa Uterus | 632 / 15404 (4.1%) | 17065 / 154040 (11.1%) | −197.8 | −195.4 | 0.37 |
| TLE3 SRX4815191 | MCF-7 Breast | 243 / 15404 (1.6%) | 10623 / 154040 (6.9%) | −197.6 | −195.2 | 0.23 |
| SMARCA4 SRX5212362 | Mel270 Others | 470 / 15404 (3.1%) | 14506 / 154040 (9.4%) | −196.9 | −194.5 | 0.32 |
| ESR1 SRX7624156 | MCF-7 Breast | 438 / 15404 (2.8%) | 13984 / 154040 (9.1%) | −196.9 | −194.4 | 0.31 |
| JUNB SRX4192882 | MCF 10A Breast | 169 / 15404 (1.1%) | 9164 / 154040 (5.9%) | −196.8 | −194.4 | 0.18 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 366 / 15404 (2.4%) | 12768 / 154040 (8.3%) | −196.4 | −194.0 | 0.29 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 395 / 15404 (2.6%) | 13251 / 154040 (8.6%) | −196.2 | −193.8 | 0.30 |
| JUNB SRX8488074 | SUM 229PE Breast | 347 / 15404 (2.3%) | 12434 / 154040 (8.1%) | −196.2 | −193.8 | 0.28 |
| SMARCA2 SRX8119677 | MeT-5A Others | 442 / 15404 (2.9%) | 14018 / 154040 (9.1%) | −195.9 | −193.5 | 0.32 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 277 / 15404 (1.8%) | 11197 / 154040 (7.3%) | −195.9 | −193.5 | 0.25 |
| JUNB SRX10119386 | MCF 10A Breast | 209 / 15404 (1.4%) | 9930 / 154040 (6.4%) | −195.9 | −193.5 | 0.21 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 825 / 15404 (5.4%) | 19820 / 154040 (12.9%) | −195.3 | −192.9 | 0.42 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1346 / 15404 (8.7%) | 5014 / 154040 (3.3%) | −194.9 | −192.5 | 2.68 |
| SMARCA4 SRX5212357 | Mel270 Others | 387 / 15404 (2.5%) | 13061 / 154040 (8.5%) | −194.5 | −192.1 | 0.30 |
| 5-mC SRX882968 | LNCAP Prostate | 2635 / 15404 (17.1%) | 13887 / 154040 (9.0%) | −194.4 | −192.0 | 1.90 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 226 / 15404 (1.5%) | 10145 / 154040 (6.6%) | −192.2 | −189.8 | 0.22 |
| SS18 SRX3468047 | Fibroblasts Others | 732 / 15404 (4.8%) | 18323 / 154040 (11.9%) | −191.2 | −188.9 | 0.40 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 464 / 15404 (3.0%) | 621 / 154040 (0.4%) | −190.9 | −188.5 | 7.47 |
| BRPF3 SRX796084 | RKO Digestive tract | 1442 / 15404 (9.4%) | 5675 / 154040 (3.7%) | −190.8 | −188.4 | 2.54 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 253 / 15404 (1.6%) | 10601 / 154040 (6.9%) | −190.7 | −188.3 | 0.24 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 1128 / 15404 (7.3%) | 3794 / 154040 (2.5%) | −190.3 | −187.9 | 2.97 |
| JUN SRX883584 | MDA-MB-231 Breast | 432 / 15404 (2.8%) | 13661 / 154040 (8.9%) | −190.0 | −187.7 | 0.32 |
| ESR1 SRX20282960 | MCF-7 Breast | 310 / 15404 (2.0%) | 11585 / 154040 (7.5%) | −189.5 | −187.1 | 0.27 |
| FOXA1 SRX100454 | T-47D Breast | 358 / 15404 (2.3%) | 12408 / 154040 (8.1%) | −189.3 | −186.9 | 0.29 |
| ESR1 SRX176861 | MCF-7 Breast | 470 / 15404 (3.1%) | 14245 / 154040 (9.2%) | −189.1 | −186.7 | 0.33 |
| ESR1 SRX371476 | MCF-7 Breast | 182 / 15404 (1.2%) | 9202 / 154040 (6.0%) | −189.0 | −186.7 | 0.20 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 484 / 15404 (3.1%) | 14454 / 154040 (9.4%) | −188.8 | −186.4 | 0.33 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 236 / 15404 (1.5%) | 10205 / 154040 (6.6%) | −188.0 | −185.6 | 0.23 |
| JUNB SRX8488089 | SUM 229PE Breast | 253 / 15404 (1.6%) | 10502 / 154040 (6.8%) | −187.4 | −185.0 | 0.24 |
| FOSL2 SRX190296 | SK-N-SH Neural | 360 / 15404 (2.3%) | 12359 / 154040 (8.0%) | −186.7 | −184.4 | 0.29 |
| FOXA1 SRX1161176 | MCF-7 Breast | 261 / 15404 (1.7%) | 10602 / 154040 (6.9%) | −185.9 | −183.6 | 0.25 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 645 / 15404 (4.2%) | 16792 / 154040 (10.9%) | −184.6 | −182.2 | 0.38 |
| ESR1 SRX1531791 | MCF-7 Breast | 259 / 15404 (1.7%) | 10522 / 154040 (6.8%) | −184.4 | −182.0 | 0.25 |
| ESR1 SRX20282939 | MCF-7 Breast | 319 / 15404 (2.1%) | 11576 / 154040 (7.5%) | −184.2 | −181.8 | 0.28 |
| FOXA1 SRX1161173 | MCF-7 Breast | 208 / 15404 (1.4%) | 9565 / 154040 (6.2%) | −184.1 | −181.7 | 0.22 |
| SMARCA4 SRX5212371 | Mel270 Others | 394 / 15404 (2.6%) | 12834 / 154040 (8.3%) | −183.9 | −181.5 | 0.31 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 249 / 15404 (1.6%) | 10302 / 154040 (6.7%) | −183.2 | −180.9 | 0.24 |
| ESR1 SRX194569 | MCF-7 Breast | 284 / 15404 (1.8%) | 10931 / 154040 (7.1%) | −183.1 | −180.7 | 0.26 |
| BRPF3 SRX796086 | RKO Digestive tract | 1377 / 15404 (8.9%) | 5400 / 154040 (3.5%) | −182.9 | −180.5 | 2.55 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 240 / 15404 (1.6%) | 10125 / 154040 (6.6%) | −182.7 | −180.4 | 0.24 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 744 / 15404 (4.8%) | 18179 / 154040 (11.8%) | −182.6 | −180.3 | 0.41 |
| ESR1 SRX371467 | MCF-7 Breast | 288 / 15404 (1.9%) | 10977 / 154040 (7.1%) | −182.3 | −179.9 | 0.26 |
| NKX2-1 SRX2164786 | A549 Lung | 478 / 15404 (3.1%) | 14109 / 154040 (9.2%) | −181.3 | −179.0 | 0.34 |
| JUND SRX150408 | HeLa Uterus | 228 / 15404 (1.5%) | 9851 / 154040 (6.4%) | −181.0 | −178.7 | 0.23 |
| VGLL1 SRX24602130 | BT-20 Breast | 278 / 15404 (1.8%) | 10757 / 154040 (7.0%) | −181.0 | −178.7 | 0.26 |
| FOXA1 SRX1161175 | MCF-7 Breast | 196 / 15404 (1.3%) | 9229 / 154040 (6.0%) | −180.5 | −178.2 | 0.21 |
| ESR1 SRX371471 | ZR-75-1 Breast | 308 / 15404 (2.0%) | 11271 / 154040 (7.3%) | −180.4 | −178.1 | 0.27 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 233 / 15404 (1.5%) | 9925 / 154040 (6.4%) | −180.3 | −178.0 | 0.23 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 625 / 15404 (4.1%) | 1318 / 154040 (0.9%) | −180.2 | −177.9 | 4.74 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 242 / 15404 (1.6%) | 10082 / 154040 (6.5%) | −180.2 | −177.9 | 0.24 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 256 / 15404 (1.7%) | 10336 / 154040 (6.7%) | −180.0 | −177.7 | 0.25 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 369 / 15404 (2.4%) | 12282 / 154040 (8.0%) | −179.6 | −177.3 | 0.30 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 474 / 15404 (3.1%) | 715 / 154040 (0.5%) | −179.6 | −177.3 | 6.63 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 252 / 15404 (1.6%) | 10252 / 154040 (6.7%) | −179.6 | −177.3 | 0.25 |
| ESR1 SRX371470 | ZR-75-1 Breast | 254 / 15404 (1.6%) | 10266 / 154040 (6.7%) | −178.9 | −176.6 | 0.25 |
| ARID1A SRX5089376 | MCF-7 Breast | 233 / 15404 (1.5%) | 9879 / 154040 (6.4%) | −178.8 | −176.5 | 0.24 |
| JUN SRX6582171 | GM07492 Others | 574 / 15404 (3.7%) | 15478 / 154040 (10.0%) | −177.7 | −175.5 | 0.37 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 512 / 15404 (3.3%) | 869 / 154040 (0.6%) | −177.6 | −175.4 | 5.89 |
| PRRX1 SRX15235713 | Hs 578T Breast | 349 / 15404 (2.3%) | 11849 / 154040 (7.7%) | −176.5 | −174.2 | 0.29 |
| EP300 SRX150579 | HeLa Uterus | 160 / 15404 (1.0%) | 8405 / 154040 (5.5%) | −176.3 | −174.1 | 0.19 |
| ESR1 SRX194572 | MCF-7 Breast | 161 / 15404 (1.0%) | 8419 / 154040 (5.5%) | −176.2 | −174.0 | 0.19 |
| TP53 SRX19538272 | U2OS Bone | 552 / 15404 (3.6%) | 1042 / 154040 (0.7%) | −175.6 | −173.3 | 5.30 |
| ESR1 SRX371468 | MCF-7 Breast | 164 / 15404 (1.1%) | 8455 / 154040 (5.5%) | −175.4 | −173.1 | 0.19 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 390 / 15404 (2.5%) | 12474 / 154040 (8.1%) | −174.9 | −172.6 | 0.31 |
| GATA3 SRX176864 | MCF-7 Breast | 199 / 15404 (1.3%) | 9120 / 154040 (5.9%) | −174.8 | −172.5 | 0.22 |
| DAXX SRX1021630 | PC-3 Prostate | 274 / 15404 (1.8%) | 10491 / 154040 (6.8%) | −174.6 | −172.3 | 0.26 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 258 / 15404 (1.7%) | 10194 / 154040 (6.6%) | −174.3 | −172.0 | 0.25 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 258 / 15404 (1.7%) | 10194 / 154040 (6.6%) | −174.3 | −172.0 | 0.25 |
| JUNB SRX10119383 | MCF 10A Breast | 169 / 15404 (1.1%) | 8519 / 154040 (5.5%) | −174.2 | −171.9 | 0.20 |
| 5-mC SRX882965 | LNCAP Prostate | 2152 / 15404 (14.0%) | 10854 / 154040 (7.0%) | −174.1 | −171.8 | 1.98 |
| FOXA1 SRX371480 | MCF-7 Breast | 184 / 15404 (1.2%) | 8805 / 154040 (5.7%) | −173.9 | −171.6 | 0.21 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 370 / 15404 (2.4%) | 12091 / 154040 (7.8%) | −173.3 | −171.0 | 0.31 |
| FOS SRX3322636 | MCF-7 Breast | 160 / 15404 (1.0%) | 8311 / 154040 (5.4%) | −173.2 | −170.9 | 0.19 |
| CIC SRX13262055 | Astrocytes Neural | 2754 / 15404 (17.9%) | 15402 / 154040 (10.0%) | −172.7 | −170.4 | 1.79 |
| YAP1 SRX10119364 | MCF 10A Breast | 220 / 15404 (1.4%) | 9451 / 154040 (6.1%) | −172.6 | −170.3 | 0.23 |
| GATA3 SRX5057632 | MCF-7 Breast | 173 / 15404 (1.1%) | 8552 / 154040 (5.6%) | −172.5 | −170.3 | 0.20 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 282 / 15404 (1.8%) | 10557 / 154040 (6.9%) | −172.1 | −169.9 | 0.27 |
| ESR1 SRX20282954 | MCF-7 Breast | 322 / 15404 (2.1%) | 11237 / 154040 (7.3%) | −171.8 | −169.6 | 0.29 |
| JUND SRX190357 | SK-N-SH Neural | 366 / 15404 (2.4%) | 11974 / 154040 (7.8%) | −171.6 | −169.4 | 0.31 |
| FOXA1 SRX1161174 | MCF-7 Breast | 302 / 15404 (2.0%) | 10885 / 154040 (7.1%) | −171.5 | −169.3 | 0.28 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 288 / 15404 (1.9%) | 10636 / 154040 (6.9%) | −171.4 | −169.2 | 0.27 |
| FOSL2 SRX190204 | A549 Lung | 275 / 15404 (1.8%) | 10390 / 154040 (6.7%) | −170.8 | −168.6 | 0.26 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 914 / 15404 (5.9%) | 20102 / 154040 (13.0%) | −169.7 | −167.5 | 0.45 |
| AR SRX1067067 | LHSAR Prostate | 522 / 15404 (3.4%) | 14394 / 154040 (9.3%) | −169.6 | −167.4 | 0.36 |
| WWTR1 SRX10119367 | MCF 10A Breast | 335 / 15404 (2.2%) | 11376 / 154040 (7.4%) | −169.2 | −167.0 | 0.29 |
| STAT3 SRX2020842 | HCC70 Breast | 541 / 15404 (3.5%) | 14663 / 154040 (9.5%) | −169.0 | −166.7 | 0.37 |
| FOXL2 SRX6957431 | KGN Gonad | 714 / 15404 (4.6%) | 17214 / 154040 (11.2%) | −168.3 | −166.1 | 0.41 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 196 / 15404 (1.3%) | 8860 / 154040 (5.8%) | −167.9 | −165.7 | 0.22 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 539 / 15404 (3.5%) | 14592 / 154040 (9.5%) | −167.9 | −165.6 | 0.37 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 222 / 15404 (1.4%) | 9342 / 154040 (6.1%) | −167.7 | −165.5 | 0.24 |
| ESR1 SRX20282972 | MCF-7 Breast | 338 / 15404 (2.2%) | 11369 / 154040 (7.4%) | −167.4 | −165.2 | 0.30 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1603 / 15404 (10.4%) | 7160 / 154040 (4.6%) | −167.3 | −165.1 | 2.24 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 472 / 15404 (3.1%) | 13536 / 154040 (8.8%) | −167.3 | −165.1 | 0.35 |
| FOXA1 SRX1787653 | MCF-7 Breast | 232 / 15404 (1.5%) | 9508 / 154040 (6.2%) | −167.1 | −165.0 | 0.24 |
| ESR1 SRX10365536 | MCF-7 Breast | 135 / 15404 (0.9%) | 7627 / 154040 (5.0%) | −167.0 | −164.8 | 0.18 |
| FOXA1 SRX11222441 | MCF-7 Breast | 217 / 15404 (1.4%) | 9217 / 154040 (6.0%) | −166.7 | −164.5 | 0.24 |
| STAT3 SRX150630 | MCF 10A Breast | 253 / 15404 (1.6%) | 9869 / 154040 (6.4%) | −166.6 | −164.4 | 0.26 |
| PBX3 SRX190343 | SK-N-SH Neural | 647 / 15404 (4.2%) | 16165 / 154040 (10.5%) | −166.6 | −164.4 | 0.40 |
| STAT3 SRX150479 | MCF 10A Breast | 257 / 15404 (1.7%) | 9936 / 154040 (6.5%) | −166.4 | −164.2 | 0.26 |
| RAC1 SRX10365541 | MCF-7 Breast | 136 / 15404 (0.9%) | 7622 / 154040 (4.9%) | −166.1 | −163.9 | 0.18 |
| ESR1 SRX2943591 | MCF-7 Breast | 190 / 15404 (1.2%) | 8691 / 154040 (5.6%) | −166.0 | −163.8 | 0.22 |
| Epitope tags SRX11470449 | Mesenchymal stem cells Others | 454 / 15404 (2.9%) | 13204 / 154040 (8.6%) | −165.9 | −163.7 | 0.34 |
| EP300 SRX2194265 | SUM 159PT Breast | 480 / 15404 (3.1%) | 13596 / 154040 (8.8%) | −165.4 | −163.2 | 0.35 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 706 / 15404 (4.6%) | 16987 / 154040 (11.0%) | −165.4 | −163.2 | 0.42 |
| FOXA2 SRX3230382 | Hep G2 Liver | 417 / 15404 (2.7%) | 12592 / 154040 (8.2%) | −165.2 | −163.1 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 136 / 15404 (0.9%) | 7591 / 154040 (4.9%) | −164.9 | −162.8 | 0.18 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 544 / 15404 (3.5%) | 14555 / 154040 (9.4%) | −164.7 | −162.5 | 0.37 |
| JUNB SRX10119384 | MCF 10A Breast | 154 / 15404 (1.0%) | 7937 / 154040 (5.2%) | −164.2 | −162.1 | 0.19 |
| TP53 SRX396254 | Fibroblasts Others | 841 / 15404 (5.5%) | 2538 / 154040 (1.6%) | −163.6 | −161.5 | 3.31 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 226 / 15404 (1.5%) | 9271 / 154040 (6.0%) | −163.0 | −160.9 | 0.24 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 408 / 15404 (2.6%) | 12372 / 154040 (8.0%) | −162.9 | −160.8 | 0.33 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 600 / 15404 (3.9%) | 1347 / 154040 (0.9%) | −162.8 | −160.6 | 4.45 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 517 / 15404 (3.4%) | 14070 / 154040 (9.1%) | −162.6 | −160.5 | 0.37 |
| MEAF6 DRX234811 | 293 Kidney | 1548 / 15404 (10.0%) | 6893 / 154040 (4.5%) | −162.3 | −160.2 | 2.25 |
| ESR1 SRX20282955 | MCF-7 Breast | 317 / 15404 (2.1%) | 10845 / 154040 (7.0%) | −162.2 | −160.1 | 0.29 |
| ING5 SRX286202 | RKO Digestive tract | 1223 / 15404 (7.9%) | 4785 / 154040 (3.1%) | −162.2 | −160.1 | 2.56 |
| FOS SRX070879 | HUVEC Cardiovascular | 318 / 15404 (2.1%) | 10859 / 154040 (7.0%) | −162.1 | −159.9 | 0.29 |
| FOXA1 SRX11222437 | MCF-7 Breast | 210 / 15404 (1.4%) | 8941 / 154040 (5.8%) | −161.9 | −159.7 | 0.23 |
| NR3C1 SRX17639412 | A549 Lung | 331 / 15404 (2.1%) | 11065 / 154040 (7.2%) | −161.7 | −159.6 | 0.30 |
| RELA SRX5938177 | FaDu Others | 265 / 15404 (1.7%) | 9914 / 154040 (6.4%) | −161.2 | −159.1 | 0.27 |
| ESR1 SRX20282973 | MCF-7 Breast | 369 / 15404 (2.4%) | 11679 / 154040 (7.6%) | −161.2 | −159.0 | 0.32 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 243 / 15404 (1.6%) | 118 / 154040 (0.1%) | −160.9 | −158.7 | 20.59 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 464 / 15404 (3.0%) | 13182 / 154040 (8.6%) | −160.7 | −158.6 | 0.35 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 223 / 15404 (1.4%) | 9147 / 154040 (5.9%) | −160.6 | −158.5 | 0.24 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 588 / 15404 (3.8%) | 15075 / 154040 (9.8%) | −160.6 | −158.4 | 0.39 |
| STAT3 SRX150536 | MCF 10A Breast | 326 / 15404 (2.1%) | 10942 / 154040 (7.1%) | −160.5 | −158.4 | 0.30 |
| FOXA1 SRX100506 | Hep G2 Liver | 414 / 15404 (2.7%) | 12386 / 154040 (8.0%) | −160.5 | −158.4 | 0.33 |
| ARID1A SRX5089379 | MCF-7 Breast | 299 / 15404 (1.9%) | 10465 / 154040 (6.8%) | −159.9 | −157.8 | 0.29 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 537 / 15404 (3.5%) | 14281 / 154040 (9.3%) | −159.9 | −157.8 | 0.38 |
| ESR1 SRX20282946 | MCF-7 Breast | 161 / 15404 (1.0%) | 7949 / 154040 (5.2%) | −159.9 | −157.7 | 0.20 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 273 / 15404 (1.8%) | 10005 / 154040 (6.5%) | −159.7 | −157.5 | 0.27 |
| AR SRX1067066 | LHSAR Prostate | 677 / 15404 (4.4%) | 16350 / 154040 (10.6%) | −159.7 | −157.5 | 0.41 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 856 / 15404 (5.6%) | 18890 / 154040 (12.3%) | −159.5 | −157.3 | 0.45 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 124 / 15404 (0.8%) | 7186 / 154040 (4.7%) | −159.4 | −157.3 | 0.17 |
| ESR1 SRX2881002 | MCF-7 Breast | 282 / 15404 (1.8%) | 10147 / 154040 (6.6%) | −159.1 | −157.0 | 0.28 |
| JUN SRX2355072 | HAEC Cardiovascular | 413 / 15404 (2.7%) | 12311 / 154040 (8.0%) | −158.9 | −156.7 | 0.34 |
| LEO1 SRX1873456 | SEM Blood | 1350 / 15404 (8.8%) | 5659 / 154040 (3.7%) | −158.5 | −156.4 | 2.39 |
| JUN SRX6582172 | Fibroblasts Others | 408 / 15404 (2.6%) | 12217 / 154040 (7.9%) | −158.5 | −156.4 | 0.33 |
| ESR1 SRX10365535 | MCF-7 Breast | 243 / 15404 (1.6%) | 9417 / 154040 (6.1%) | −157.8 | −155.7 | 0.26 |
| NR3C1 SRX2609664 | HASM2 Lung | 440 / 15404 (2.9%) | 12699 / 154040 (8.2%) | −157.7 | −155.6 | 0.35 |
| FOXA1 SRX3923514 | MCF-7 Breast | 321 / 15404 (2.1%) | 10766 / 154040 (7.0%) | −157.7 | −155.6 | 0.30 |
| FOXA1 SRX3931043 | MCF-7 Breast | 312 / 15404 (2.0%) | 10611 / 154040 (6.9%) | −157.6 | −155.5 | 0.29 |
| FOXA2 SRX100448 | Hep G2 Liver | 347 / 15404 (2.3%) | 11190 / 154040 (7.3%) | −157.3 | −155.2 | 0.31 |
| ESR1 SRX20282940 | MCF-7 Breast | 338 / 15404 (2.2%) | 11033 / 154040 (7.2%) | −157.1 | −155.0 | 0.31 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 246 / 15404 (1.6%) | 9449 / 154040 (6.1%) | −157.0 | −154.9 | 0.26 |
| AR SRX9469988 | LAPC-4 Prostate | 426 / 15404 (2.8%) | 12442 / 154040 (8.1%) | −156.6 | −154.5 | 0.34 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 219 / 15404 (1.4%) | 8941 / 154040 (5.8%) | −156.4 | −154.3 | 0.24 |
| ESR1 SRX4367192 | MCF-7 Breast | 654 / 15404 (4.2%) | 15890 / 154040 (10.3%) | −156.4 | −154.3 | 0.41 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 620 / 15404 (4.0%) | 15384 / 154040 (10.0%) | −156.2 | −154.1 | 0.40 |
| ESR1 SRX371477 | MCF-7 Breast | 135 / 15404 (0.9%) | 7316 / 154040 (4.7%) | −156.0 | −153.9 | 0.18 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 414 / 15404 (2.7%) | 12228 / 154040 (7.9%) | −156.0 | −153.9 | 0.34 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 338 / 15404 (2.2%) | 10984 / 154040 (7.1%) | −155.7 | −153.6 | 0.31 |
| NR2F2 SRX190293 | MCF-7 Breast | 327 / 15404 (2.1%) | 10798 / 154040 (7.0%) | −155.6 | −153.6 | 0.30 |
| ARID5B SRX3230377 | Hep G2 Liver | 819 / 15404 (5.3%) | 18205 / 154040 (11.8%) | −155.3 | −153.2 | 0.45 |
| TEAD1 SRX3401272 | MCF-7 Breast | 227 / 15404 (1.5%) | 9050 / 154040 (5.9%) | −155.1 | −153.1 | 0.25 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 286 / 15404 (1.9%) | 10082 / 154040 (6.5%) | −154.9 | −152.8 | 0.28 |
| ESR1 SRX371475 | BT-474 Breast | 139 / 15404 (0.9%) | 7367 / 154040 (4.8%) | −154.9 | −152.8 | 0.19 |
| FOXA1 SRX190181 | A549 Lung | 211 / 15404 (1.4%) | 8748 / 154040 (5.7%) | −154.9 | −152.8 | 0.24 |
| MEAF6 DRX300417 | 293 Kidney | 1412 / 15404 (9.2%) | 6145 / 154040 (4.0%) | −154.3 | −152.2 | 2.30 |
| STAT5B SRX831881 | CD8+ T cells Blood | 246 / 15404 (1.6%) | 140 / 154040 (0.1%) | −154.2 | −152.1 | 17.57 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 186 / 15404 (1.2%) | 8257 / 154040 (5.4%) | −154.1 | −152.0 | 0.23 |
| TLE3 SRX4815192 | MCF-7 Breast | 280 / 15404 (1.8%) | 9948 / 154040 (6.5%) | −154.0 | −151.9 | 0.28 |
| FOS SRX3322637 | MCF-7 Breast | 144 / 15404 (0.9%) | 7437 / 154040 (4.8%) | −153.8 | −151.7 | 0.19 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 328 / 15404 (2.1%) | 10753 / 154040 (7.0%) | −153.8 | −151.7 | 0.31 |
| ESR1 SRX2881000 | MCF-7 Breast | 267 / 15404 (1.7%) | 9702 / 154040 (6.3%) | −153.3 | −151.3 | 0.28 |
| EP300 SRX2194266 | SUM 159PT Breast | 555 / 15404 (3.6%) | 14304 / 154040 (9.3%) | −153.0 | −151.0 | 0.39 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 288 / 15404 (1.9%) | 10050 / 154040 (6.5%) | −152.8 | −150.7 | 0.29 |
| EP300 SRX176885 | MCF-7 Breast | 148 / 15404 (1.0%) | 7482 / 154040 (4.9%) | −152.7 | −150.7 | 0.20 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 463 / 15404 (3.0%) | 12884 / 154040 (8.4%) | −152.7 | −150.6 | 0.36 |
| GATA3 SRX5457550 | MCF-7 Breast | 356 / 15404 (2.3%) | 11179 / 154040 (7.3%) | −152.7 | −150.6 | 0.32 |
| FOXA1 SRX3931055 | MCF-7 Breast | 260 / 15404 (1.7%) | 9556 / 154040 (6.2%) | −152.6 | −150.6 | 0.27 |
| EP300 SRX2671813 | Fibroblasts Others | 252 / 15404 (1.6%) | 9397 / 154040 (6.1%) | −152.0 | −149.9 | 0.27 |
| FOXA1 SRX3931054 | MCF-7 Breast | 292 / 15404 (1.9%) | 10088 / 154040 (6.5%) | −151.9 | −149.9 | 0.29 |
| PGR SRX1012655 | MCF-7 Breast | 188 / 15404 (1.2%) | 8232 / 154040 (5.3%) | −151.9 | −149.9 | 0.23 |
| FOS SRX150664 | HUVEC Cardiovascular | 426 / 15404 (2.8%) | 12277 / 154040 (8.0%) | −151.8 | −149.7 | 0.35 |
| ESR1 SRX330067 | MCF-7 Breast | 280 / 15404 (1.8%) | 9879 / 154040 (6.4%) | −151.8 | −149.7 | 0.28 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 220 / 15404 (1.4%) | 8816 / 154040 (5.7%) | −151.7 | −149.6 | 0.25 |
| JUND SRX699738 | HCASMC Cardiovascular | 449 / 15404 (2.9%) | 12630 / 154040 (8.2%) | −151.5 | −149.5 | 0.36 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 300 / 15404 (1.9%) | 10207 / 154040 (6.6%) | −151.4 | −149.3 | 0.29 |
| TRP47 SRX4548329 | THP-1 Blood | 2338 / 15404 (15.2%) | 12859 / 154040 (8.3%) | −150.9 | −148.9 | 1.82 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 410 / 15404 (2.7%) | 11987 / 154040 (7.8%) | −150.7 | −148.7 | 0.34 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 180 / 15404 (1.2%) | 8044 / 154040 (5.2%) | −150.6 | −148.5 | 0.22 |
| ZEB1 SRX13298925 | MCF-7 Breast | 175 / 15404 (1.1%) | 7948 / 154040 (5.2%) | −150.6 | −148.5 | 0.22 |
| Epitope tags SRX10549778 | K-562 Blood | 1036 / 15404 (6.7%) | 3827 / 154040 (2.5%) | −150.6 | −148.5 | 2.71 |
| FOXA1 SRX028634 | MCF-7 Breast | 141 / 15404 (0.9%) | 7272 / 154040 (4.7%) | −150.2 | −148.2 | 0.19 |
| FOXA1 SRX11222442 | MCF-7 Breast | 207 / 15404 (1.3%) | 8534 / 154040 (5.5%) | −150.2 | −148.1 | 0.24 |
| JUN SRX6582163 | BJ-5ta Epidermis | 405 / 15404 (2.6%) | 11886 / 154040 (7.7%) | −150.1 | −148.0 | 0.34 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 993 / 15404 (6.4%) | 20374 / 154040 (13.2%) | −149.9 | −147.9 | 0.49 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 483 / 15404 (3.1%) | 13087 / 154040 (8.5%) | −149.6 | −147.6 | 0.37 |
| ESR1 SRX371474 | BT-474 Breast | 130 / 15404 (0.8%) | 7030 / 154040 (4.6%) | −149.6 | −147.5 | 0.18 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 215 / 15404 (1.4%) | 8644 / 154040 (5.6%) | −149.0 | −147.0 | 0.25 |
| ESR1 SRX8537722 | MCF-7 Breast | 291 / 15404 (1.9%) | 9977 / 154040 (6.5%) | −148.9 | −146.9 | 0.29 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 270 / 15404 (1.8%) | 9608 / 154040 (6.2%) | −148.7 | −146.7 | 0.28 |
| NR3C1 SRX2609665 | HASM2 Lung | 359 / 15404 (2.3%) | 11099 / 154040 (7.2%) | −148.7 | −146.7 | 0.32 |
| FOXA1 SRX1787652 | MCF-7 Breast | 186 / 15404 (1.2%) | 8093 / 154040 (5.3%) | −148.6 | −146.6 | 0.23 |
| ESR1 SRX20282953 | MCF-7 Breast | 253 / 15404 (1.6%) | 9302 / 154040 (6.0%) | −148.4 | −146.4 | 0.27 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 423 / 15404 (2.7%) | 12113 / 154040 (7.9%) | −148.4 | −146.4 | 0.35 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 373 / 15404 (2.4%) | 11311 / 154040 (7.3%) | −148.4 | −146.4 | 0.33 |
| HMG20A SRX2630163 | Hep G2 Liver | 163 / 15404 (1.1%) | 7650 / 154040 (5.0%) | −148.3 | −146.3 | 0.21 |
| ESR1 SRX10365532 | MCF-7 Breast | 161 / 15404 (1.0%) | 7597 / 154040 (4.9%) | −147.9 | −145.9 | 0.21 |
| FOXA1 SRX1447317 | MCF-7 Breast | 204 / 15404 (1.3%) | 8388 / 154040 (5.4%) | −147.2 | −145.2 | 0.24 |
| WWTR1 SRX10119378 | MCF 10A Breast | 345 / 15404 (2.2%) | 10813 / 154040 (7.0%) | −147.1 | −145.1 | 0.32 |
| JUN SRX6582164 | BJ-5ta Epidermis | 415 / 15404 (2.7%) | 11936 / 154040 (7.7%) | −147.0 | −145.0 | 0.35 |
| CEBPB SRX190345 | MCF-7 Breast | 236 / 15404 (1.5%) | 8956 / 154040 (5.8%) | −146.9 | −144.9 | 0.26 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 394 / 15404 (2.6%) | 11596 / 154040 (7.5%) | −146.8 | −144.8 | 0.34 |
| FOXA1 SRX190282 | A549 Lung | 216 / 15404 (1.4%) | 8590 / 154040 (5.6%) | −146.7 | −144.7 | 0.25 |
| FOXA1 SRX13814018 | 5637 Others | 188 / 15404 (1.2%) | 8068 / 154040 (5.2%) | −146.4 | −144.4 | 0.23 |
| AR SRX9109110 | MDA-MB-453 Breast | 635 / 15404 (4.1%) | 15232 / 154040 (9.9%) | −146.3 | −144.3 | 0.42 |
| NR3C1 SRX10976921 | A549 Lung | 215 / 15404 (1.4%) | 8554 / 154040 (5.6%) | −146.2 | −144.2 | 0.25 |
| SOX13 SRX2636248 | Hep G2 Liver | 454 / 15404 (2.9%) | 12513 / 154040 (8.1%) | −146.1 | −144.0 | 0.36 |
| EP300 SRX100540 | SK-N-SH Neural | 481 / 15404 (3.1%) | 12927 / 154040 (8.4%) | −146.0 | −144.0 | 0.37 |
| ARID5B SRX10475139 | Hep G2 Liver | 356 / 15404 (2.3%) | 10955 / 154040 (7.1%) | −146.0 | −143.9 | 0.32 |
| YAP1 SRX1038945 | IMR-90 Lung | 238 / 15404 (1.5%) | 8953 / 154040 (5.8%) | −145.8 | −143.8 | 0.27 |
| EP300 SRX1012648 | MCF-7 Breast | 138 / 15404 (0.9%) | 7083 / 154040 (4.6%) | −145.7 | −143.7 | 0.19 |
| JUN SRX7277180 | GM07492 Others | 258 / 15404 (1.7%) | 9305 / 154040 (6.0%) | −145.7 | −143.7 | 0.28 |
| Epitope tags SRX11470532 | Mesenchymal stem cells Others | 434 / 15404 (2.8%) | 12182 / 154040 (7.9%) | −145.6 | −143.6 | 0.36 |
| FOXA1 SRX028635 | MCF-7 Breast | 148 / 15404 (1.0%) | 7274 / 154040 (4.7%) | −145.6 | −143.6 | 0.20 |
| SMARCA4 SRX5982340 | A549 Lung | 110 / 15404 (0.7%) | 6504 / 154040 (4.2%) | −145.5 | −143.5 | 0.17 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 613 / 15404 (4.0%) | 14880 / 154040 (9.7%) | −145.5 | −143.5 | 0.41 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 274 / 15404 (1.8%) | 9568 / 154040 (6.2%) | −145.4 | −143.4 | 0.29 |
| GATA3 SRX6712581 | MCF-7 Breast | 264 / 15404 (1.7%) | 9391 / 154040 (6.1%) | −145.2 | −143.2 | 0.28 |
| JUN SRX2355073 | HAEC Cardiovascular | 419 / 15404 (2.7%) | 11929 / 154040 (7.7%) | −145.0 | −143.0 | 0.35 |
| FOXA1 SRX15430999 | T-47D Breast | 367 / 15404 (2.4%) | 11102 / 154040 (7.2%) | −145.0 | −143.0 | 0.33 |
| NFYB SRX16608147 | HeLa Uterus | 247 / 15404 (1.6%) | 167 / 154040 (0.1%) | −144.9 | −143.0 | 14.79 |
| GATAD2A SRX2636506 | Hep G2 Liver | 427 / 15404 (2.8%) | 12051 / 154040 (7.8%) | −144.9 | −142.9 | 0.35 |
| NR3C1 SRX2609662 | HASM2 Lung | 401 / 15404 (2.6%) | 11636 / 154040 (7.6%) | −144.8 | −142.8 | 0.34 |
| CEBPA SRX2630241 | Hep G2 Liver | 401 / 15404 (2.6%) | 11639 / 154040 (7.6%) | −144.8 | −142.8 | 0.34 |
| ESR1 SRX10365533 | MCF-7 Breast | 140 / 15404 (0.9%) | 7091 / 154040 (4.6%) | −144.7 | −142.8 | 0.20 |
| ESR1 SRX20282971 | MCF-7 Breast | 321 / 15404 (2.1%) | 10338 / 154040 (6.7%) | −144.7 | −142.8 | 0.31 |
| PROX1 SRX3230397 | Hep G2 Liver | 226 / 15404 (1.5%) | 8707 / 154040 (5.7%) | −144.7 | −142.7 | 0.26 |
| NR3C1 SRX10977373 | A549 Lung | 161 / 15404 (1.0%) | 7486 / 154040 (4.9%) | −144.1 | −142.1 | 0.22 |
| ESR1 SRX2943589 | MCF-7 Breast | 154 / 15404 (1.0%) | 7341 / 154040 (4.8%) | −143.8 | −141.9 | 0.21 |
| ESR1 SRX5323873 | MCF-7 Breast | 408 / 15404 (2.6%) | 11705 / 154040 (7.6%) | −143.5 | −141.6 | 0.35 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 275 / 15404 (1.8%) | 9522 / 154040 (6.2%) | −143.5 | −141.5 | 0.29 |
| JUNB SRX10119385 | MCF 10A Breast | 126 / 15404 (0.8%) | 6776 / 154040 (4.4%) | −143.5 | −141.5 | 0.19 |
| ARID1A SRX5679788 | 12Z Others | 119 / 15404 (0.8%) | 6629 / 154040 (4.3%) | −143.5 | −141.5 | 0.18 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 475 / 15404 (3.1%) | 12738 / 154040 (8.3%) | −143.3 | −141.3 | 0.37 |
| FOXA1 SRX1961157 | T-47D Breast | 362 / 15404 (2.4%) | 10961 / 154040 (7.1%) | −143.3 | −141.3 | 0.33 |
| RNF2 SRX18954719 | SCC-25 Others | 445 / 15404 (2.9%) | 12271 / 154040 (8.0%) | −143.2 | −141.2 | 0.36 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 223 / 15404 (1.4%) | 8609 / 154040 (5.6%) | −143.2 | −141.2 | 0.26 |
| NR3C1 SRX10977372 | A549 Lung | 175 / 15404 (1.1%) | 7722 / 154040 (5.0%) | −143.1 | −141.2 | 0.23 |
| DNA-RNA hybrid SRX21658480 | U2OS Bone | 502 / 15404 (3.3%) | 1070 / 154040 (0.7%) | −143.0 | −141.1 | 4.69 |
| NR3C1 SRX10977357 | A549 Lung | 189 / 15404 (1.2%) | 7978 / 154040 (5.2%) | −142.9 | −140.9 | 0.24 |
| ESR1 SRX330070 | MCF-7 Breast | 152 / 15404 (1.0%) | 7273 / 154040 (4.7%) | −142.8 | −140.9 | 0.21 |
| FOXL2 SRX6957477 | KGN Gonad | 343 / 15404 (2.2%) | 10635 / 154040 (6.9%) | −142.8 | −140.8 | 0.32 |
| FOXA1 SRX1161203 | T-47D Breast | 232 / 15404 (1.5%) | 8747 / 154040 (5.7%) | −142.6 | −140.6 | 0.27 |
| ESR1 SRX3110725 | MCF-7 Breast | 290 / 15404 (1.9%) | 9750 / 154040 (6.3%) | −142.6 | −140.6 | 0.30 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 475 / 15404 (3.1%) | 12703 / 154040 (8.2%) | −142.4 | −140.4 | 0.37 |
| FOXA1 SRX11222438 | MCF-7 Breast | 167 / 15404 (1.1%) | 7547 / 154040 (4.9%) | −142.3 | −140.3 | 0.22 |
| EP300 SRX1012644 | MCF-7 Breast | 132 / 15404 (0.9%) | 6859 / 154040 (4.5%) | −142.3 | −140.3 | 0.19 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 151 / 15404 (1.0%) | 7235 / 154040 (4.7%) | −142.1 | −140.2 | 0.21 |
| ESR1 SRX1531796 | MCF-7 Breast | 163 / 15404 (1.1%) | 7462 / 154040 (4.8%) | −142.1 | −140.1 | 0.22 |
| ESR1 SRX1012629 | MCF-7 Breast | 197 / 15404 (1.3%) | 8098 / 154040 (5.3%) | −142.0 | −140.1 | 0.24 |
| ESR1 SRX330069 | MCF-7 Breast | 189 / 15404 (1.2%) | 7952 / 154040 (5.2%) | −142.0 | −140.0 | 0.24 |
| SREBF2 SRX5359048 | HCC70 Breast | 1511 / 15404 (9.8%) | 7074 / 154040 (4.6%) | −141.9 | −140.0 | 2.14 |
| NR3C1 SRX18884271 | A549 Lung | 160 / 15404 (1.0%) | 7396 / 154040 (4.8%) | −141.7 | −139.8 | 0.22 |
| ESR1 SRX20282959 | MCF-7 Breast | 120 / 15404 (0.8%) | 6597 / 154040 (4.3%) | −141.6 | −139.6 | 0.18 |
| FOXA1 SRX3923517 | MCF-7 Breast | 233 / 15404 (1.5%) | 8730 / 154040 (5.7%) | −141.5 | −139.6 | 0.27 |
| FOXA1 SRX1787655 | MCF-7 Breast | 156 / 15404 (1.0%) | 7306 / 154040 (4.7%) | −141.3 | −139.4 | 0.21 |
| Epitope tags DRX443510 | 293 Kidney | 1305 / 15404 (8.5%) | 5696 / 154040 (3.7%) | −141.3 | −139.4 | 2.29 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 482 / 15404 (3.1%) | 12769 / 154040 (8.3%) | −141.3 | −139.3 | 0.38 |
| MITF SRX7368255 | Hermes 3C Epidermis | 974 / 15404 (6.3%) | 19751 / 154040 (12.8%) | −141.2 | −139.2 | 0.49 |
| BRPF1 SRX10606575 | GIST-T1 Digestive tract | 614 / 15404 (4.0%) | 1616 / 154040 (1.0%) | −140.6 | −138.7 | 3.80 |
| EP300 SRX10976625 | A549 Lung | 180 / 15404 (1.2%) | 7743 / 154040 (5.0%) | −140.6 | −138.6 | 0.23 |
| Epitope tags SRX11470445 | Mesenchymal stem cells Others | 428 / 15404 (2.8%) | 11912 / 154040 (7.7%) | −140.4 | −138.5 | 0.36 |
| DNA-RNA hybrid SRX20083260 | SH-SY5Y Neural | 802 / 15404 (5.2%) | 2614 / 154040 (1.7%) | −140.4 | −138.4 | 3.07 |
| ESR1 SRX1012632 | MCF-7 Breast | 149 / 15404 (1.0%) | 7136 / 154040 (4.6%) | −140.2 | −138.3 | 0.21 |
| FOXA1 SRX6878603 | LNCAP Prostate | 371 / 15404 (2.4%) | 10999 / 154040 (7.1%) | −140.2 | −138.2 | 0.34 |
| SP1 SRX190269 | A549 Lung | 497 / 15404 (3.2%) | 12958 / 154040 (8.4%) | −140.1 | −138.2 | 0.38 |
| SSRP1 SRX3436567 | HT-1080 Bone | 371 / 15404 (2.4%) | 563 / 154040 (0.4%) | −139.9 | −138.0 | 6.59 |
| ARID1A SRX5089385 | MCF-7 Breast | 245 / 15404 (1.6%) | 8893 / 154040 (5.8%) | −139.9 | −138.0 | 0.28 |
| ARID1A SRX5679787 | 12Z Others | 110 / 15404 (0.7%) | 6340 / 154040 (4.1%) | −139.8 | −137.9 | 0.17 |
| DNA-RNA hybrid SRX20083259 | SH-SY5Y Neural | 741 / 15404 (4.8%) | 2286 / 154040 (1.5%) | −139.7 | −137.8 | 3.24 |
| EP300 SRX176883 | MCF-7 Breast | 141 / 15404 (0.9%) | 6966 / 154040 (4.5%) | −139.7 | −137.7 | 0.20 |
| FOXA1 SRX100477 | Hep G2 Liver | 386 / 15404 (2.5%) | 11218 / 154040 (7.3%) | −139.5 | −137.6 | 0.34 |
| GATAD2A SRX2636507 | Hep G2 Liver | 365 / 15404 (2.4%) | 10882 / 154040 (7.1%) | −139.5 | −137.6 | 0.34 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 529 / 15404 (3.4%) | 13412 / 154040 (8.7%) | −139.5 | −137.5 | 0.39 |
| ESR1 SRX20282938 | MCF-7 Breast | 264 / 15404 (1.7%) | 9204 / 154040 (6.0%) | −139.4 | −137.5 | 0.29 |
| ESR1 SRX3123829 | MCF-7 Breast | 182 / 15404 (1.2%) | 7736 / 154040 (5.0%) | −139.2 | −137.3 | 0.24 |
| FOS SRX7760064 | CFPAC-1 Pancreas | 265 / 15404 (1.7%) | 9208 / 154040 (6.0%) | −138.9 | −137.0 | 0.29 |
| EP300 SRX10976215 | A549 Lung | 303 / 15404 (2.0%) | 9851 / 154040 (6.4%) | −138.9 | −137.0 | 0.31 |
| FOXA1 SRX1787651 | MCF-7 Breast | 183 / 15404 (1.2%) | 7743 / 154040 (5.0%) | −138.9 | −136.9 | 0.24 |
| FOXA2 SRX2368888 | Ker-CT Epidermis | 323 / 15404 (2.1%) | 10174 / 154040 (6.6%) | −138.8 | −136.9 | 0.32 |
| EP300 SRX1012643 | MCF-7 Breast | 102 / 15404 (0.7%) | 6142 / 154040 (4.0%) | −138.8 | −136.9 | 0.17 |
| JUNB SRX2443774 | A549 Lung | 129 / 15404 (0.8%) | 6699 / 154040 (4.3%) | −138.7 | −136.8 | 0.19 |
| TLE3 SRX4815194 | SUM 149PT Breast | 246 / 15404 (1.6%) | 8869 / 154040 (5.8%) | −138.7 | −136.8 | 0.28 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 270 / 15404 (1.8%) | 9283 / 154040 (6.0%) | −138.6 | −136.7 | 0.29 |
| FOXA1 SRX1961158 | T-47D Breast | 337 / 15404 (2.2%) | 10391 / 154040 (6.7%) | −138.5 | −136.5 | 0.32 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 320 / 15404 (2.1%) | 10107 / 154040 (6.6%) | −138.3 | −136.4 | 0.32 |
| FOXA1 SRX3923516 | MCF-7 Breast | 240 / 15404 (1.6%) | 8750 / 154040 (5.7%) | −138.2 | −136.3 | 0.27 |
| CEBPA SRX4705113 | MOLM-13 Blood | 797 / 15404 (5.2%) | 17210 / 154040 (11.2%) | −138.2 | −136.3 | 0.46 |
| SMAD3 SRX366168 | NCI-H441 Lung | 288 / 15404 (1.9%) | 9565 / 154040 (6.2%) | −137.9 | −136.0 | 0.30 |
| GATA3 SRX100559 | T-47D Breast | 381 / 15404 (2.5%) | 11083 / 154040 (7.2%) | −137.9 | −136.0 | 0.34 |
| TFAP2C SRX018833 | MCF-7 Breast | 300 / 15404 (1.9%) | 9765 / 154040 (6.3%) | −137.9 | −136.0 | 0.31 |
| FOXA1 SRX5323843 | MCF-7 Breast | 167 / 15404 (1.1%) | 7416 / 154040 (4.8%) | −137.9 | −136.0 | 0.23 |
| SP1 SRX190358 | HCT 116 Digestive tract | 534 / 15404 (3.5%) | 13425 / 154040 (8.7%) | −137.8 | −135.9 | 0.40 |
| ESR1 SRX4451213 | MCF-7 Breast | 348 / 15404 (2.3%) | 10542 / 154040 (6.8%) | −137.6 | −135.7 | 0.33 |
| NR3C1 SRX2609666 | HASM2 Lung | 328 / 15404 (2.1%) | 10217 / 154040 (6.6%) | −137.6 | −135.7 | 0.32 |
| CEBPB SRX2194250 | SUM 159PT Breast | 413 / 15404 (2.7%) | 11565 / 154040 (7.5%) | −137.3 | −135.4 | 0.36 |
| FOSL1 SRX2585779 | MDA-MB-231 Breast | 153 / 15404 (1.0%) | 7131 / 154040 (4.6%) | −137.3 | −135.4 | 0.21 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 277 / 15404 (1.8%) | 9346 / 154040 (6.1%) | −137.0 | −135.1 | 0.30 |
| FOXA2 SRX6441751 | CFPAC-1 Pancreas | 143 / 15404 (0.9%) | 6924 / 154040 (4.5%) | −137.0 | −135.1 | 0.21 |
| ARID1A SRX5089391 | MCF-7 Breast | 182 / 15404 (1.2%) | 7669 / 154040 (5.0%) | −137.0 | −135.1 | 0.24 |
| NR3C1 SRX2609659 | HASM2 Lung | 404 / 15404 (2.6%) | 11399 / 154040 (7.4%) | −136.7 | −134.8 | 0.35 |
| FOXA1 SRX3923518 | MCF-7 Breast | 231 / 15404 (1.5%) | 8540 / 154040 (5.5%) | −136.6 | −134.7 | 0.27 |
| WWTR1 SRX10119368 | MCF 10A Breast | 231 / 15404 (1.5%) | 8544 / 154040 (5.5%) | −136.6 | −134.7 | 0.27 |
| NR3C1 SRX19024866 | MCF-7 Breast | 103 / 15404 (0.7%) | 6103 / 154040 (4.0%) | −136.6 | −134.7 | 0.17 |
| MAML1 SRX8970969 | Squamous cell carcinoma Others | 328 / 15404 (2.1%) | 10178 / 154040 (6.6%) | −136.5 | −134.6 | 0.32 |
| FOXA1 SRX3923519 | MCF-7 Breast | 204 / 15404 (1.3%) | 8051 / 154040 (5.2%) | −136.4 | −134.5 | 0.25 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 223 / 15404 (1.4%) | 8389 / 154040 (5.4%) | −136.3 | −134.4 | 0.27 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 564 / 15404 (3.7%) | 13804 / 154040 (9.0%) | −136.1 | −134.2 | 0.41 |
| ESR1 SRX8537723 | MCF-7 Breast | 269 / 15404 (1.7%) | 9173 / 154040 (6.0%) | −135.8 | −133.9 | 0.29 |
| ESR1 SRX10365558 | MCF-7 Breast | 226 / 15404 (1.5%) | 8424 / 154040 (5.5%) | −135.7 | −133.8 | 0.27 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1601 / 15404 (10.4%) | 7850 / 154040 (5.1%) | −135.7 | −133.8 | 2.04 |
| MYC SRX150570 | MCF 10A Breast | 215 / 15404 (1.4%) | 8224 / 154040 (5.3%) | −135.6 | −133.7 | 0.26 |
| ESR1 SRX1469949 | MCF-7 Breast | 185 / 15404 (1.2%) | 7674 / 154040 (5.0%) | −135.4 | −133.5 | 0.24 |
| RELA SRX7055007 | HAEC Cardiovascular | 630 / 15404 (4.1%) | 14740 / 154040 (9.6%) | −135.4 | −133.5 | 0.43 |
| SMARCA4 SRX5982364 | A549 Lung | 90 / 15404 (0.6%) | 5782 / 154040 (3.8%) | −135.2 | −133.3 | 0.16 |
| TFAP2C SRX128099 | MCF-7 Breast | 305 / 15404 (2.0%) | 9754 / 154040 (6.3%) | −135.1 | −133.2 | 0.31 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 614 / 15404 (4.0%) | 14495 / 154040 (9.4%) | −135.1 | −133.2 | 0.42 |
| EP300 SRX717859 | HeLa Uterus | 167 / 15404 (1.1%) | 7327 / 154040 (4.8%) | −135.0 | −133.1 | 0.23 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 249 / 15404 (1.6%) | 8804 / 154040 (5.7%) | −135.0 | −133.1 | 0.28 |
| ESR1 SRX2912055 | MCF-7 Breast | 117 / 15404 (0.8%) | 6347 / 154040 (4.1%) | −134.9 | −133.0 | 0.18 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 244 / 15404 (1.6%) | 8714 / 154040 (5.7%) | −134.9 | −133.0 | 0.28 |
| Epitope tags SRX15939724 | RD Muscle | 298 / 15404 (1.9%) | 9628 / 154040 (6.3%) | −134.9 | −133.0 | 0.31 |
| MECOM SRX23677885 | HNT-34 Blood | 1553 / 15404 (10.1%) | 7531 / 154040 (4.9%) | −134.7 | −132.9 | 2.06 |
| JUN SRX6582165 | BJ-5ta Epidermis | 673 / 15404 (4.4%) | 15322 / 154040 (9.9%) | −134.6 | −132.7 | 0.44 |
| ESR1 SRX5323871 | MCF-7 Breast | 374 / 15404 (2.4%) | 10852 / 154040 (7.0%) | −134.6 | −132.7 | 0.34 |
| EP300 SRX717860 | HeLa Uterus | 206 / 15404 (1.3%) | 8028 / 154040 (5.2%) | −134.5 | −132.6 | 0.26 |
| SMARCA4 SRX5982341 | A549 Lung | 89 / 15404 (0.6%) | 5741 / 154040 (3.7%) | −134.4 | −132.5 | 0.16 |
| JUN SRX150358 | HUVEC Cardiovascular | 216 / 15404 (1.4%) | 8194 / 154040 (5.3%) | −134.1 | −132.2 | 0.26 |
| ARID1A SRX5089388 | MCF-7 Breast | 168 / 15404 (1.1%) | 7316 / 154040 (4.7%) | −134.0 | −132.2 | 0.23 |
| JUNB SRX4677294 | CFPAC-1 Pancreas | 209 / 15404 (1.4%) | 8069 / 154040 (5.2%) | −134.0 | −132.1 | 0.26 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 225 / 15404 (1.5%) | 8349 / 154040 (5.4%) | −133.9 | −132.0 | 0.27 |
| FOXA1 SRX5323829 | T-47D Breast | 186 / 15404 (1.2%) | 7640 / 154040 (5.0%) | −133.7 | −131.8 | 0.24 |
| DNA-RNA hybrid SRX20083265 | SH-SY5Y Neural | 690 / 15404 (4.5%) | 2085 / 154040 (1.4%) | −133.6 | −131.7 | 3.31 |
| NR3C1 SRX8520802 | HCC1187 Breast | 248 / 15404 (1.6%) | 8740 / 154040 (5.7%) | −133.6 | −131.7 | 0.28 |
| NR3C1 SRX18884260 | A549 Lung | 192 / 15404 (1.2%) | 7750 / 154040 (5.0%) | −133.6 | −131.7 | 0.25 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 375 / 15404 (2.4%) | 10816 / 154040 (7.0%) | −133.1 | −131.2 | 0.35 |
| NANOG SRX017277 | hESC H1 Pluripotent stem cell | 123 / 15404 (0.8%) | 6414 / 154040 (4.2%) | −133.1 | −131.2 | 0.19 |
| Epitope tags SRX5877912 | U2OS Bone | 1967 / 15404 (12.8%) | 31879 / 154040 (20.7%) | −133.0 | −131.2 | 0.62 |
| FOXA1 SRX3931033 | MCF-7 Breast | 213 / 15404 (1.4%) | 8110 / 154040 (5.3%) | −133.0 | −131.2 | 0.26 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1387 / 15404 (9.0%) | 6422 / 154040 (4.2%) | −132.9 | −131.0 | 2.16 |
| GFP SRX6949256 | HeLa Uterus | 378 / 15404 (2.5%) | 10854 / 154040 (7.0%) | −132.8 | −130.9 | 0.35 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1695 / 15404 (11.0%) | 8592 / 154040 (5.6%) | −132.8 | −130.9 | 1.97 |
| FOXA1 SRX1389379 | CFPAC-1 Pancreas | 231 / 15404 (1.5%) | 8418 / 154040 (5.5%) | −132.7 | −130.9 | 0.27 |
| ESR1 SRX1012633 | MCF-7 Breast | 168 / 15404 (1.1%) | 7276 / 154040 (4.7%) | −132.7 | −130.8 | 0.23 |
| ZEB1 SRX13298924 | MCF-7 Breast | 154 / 15404 (1.0%) | 7007 / 154040 (4.5%) | −132.5 | −130.7 | 0.22 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 388 / 15404 (2.5%) | 10987 / 154040 (7.1%) | −132.1 | −130.3 | 0.35 |
| SMARCA2 SRX5982361 | A549 Lung | 98 / 15404 (0.6%) | 5863 / 154040 (3.8%) | −131.9 | −130.1 | 0.17 |
| ESR1 SRX5323878 | MCF-7 Breast | 347 / 15404 (2.3%) | 10324 / 154040 (6.7%) | −131.8 | −129.9 | 0.34 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 627 / 15404 (4.1%) | 14547 / 154040 (9.4%) | −131.6 | −129.8 | 0.43 |
| HOXC5 SRX2731653 | PC-3 Prostate | 278 / 15404 (1.8%) | 9188 / 154040 (6.0%) | −131.6 | −129.7 | 0.30 |
| FOS SRX7760063 | CFPAC-1 Pancreas | 210 / 15404 (1.4%) | 8007 / 154040 (5.2%) | −131.5 | −129.6 | 0.26 |
| CDK9 SRX7366781 | MCF-7 Breast | 213 / 15404 (1.4%) | 127 / 154040 (0.1%) | −131.3 | −129.5 | 16.77 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1436 / 15404 (9.3%) | 6799 / 154040 (4.4%) | −131.2 | −129.3 | 2.11 |
| NR3C1 SRX10976392 | A549 Lung | 145 / 15404 (0.9%) | 6786 / 154040 (4.4%) | −130.9 | −129.1 | 0.21 |
| CDK9 SRX7366783 | MCF-7 Breast | 220 / 15404 (1.4%) | 144 / 154040 (0.1%) | −130.8 | −129.0 | 15.28 |
| BMI1 SRX7196721 | SF8628 Neural | 1500 / 15404 (9.7%) | 7255 / 154040 (4.7%) | −130.7 | −128.9 | 2.07 |
| ARID1A SRX5089382 | MCF-7 Breast | 249 / 15404 (1.6%) | 8662 / 154040 (5.6%) | −130.7 | −128.8 | 0.29 |
| VGLL1 SRX18013277 | FULVR Breast | 146 / 15404 (0.9%) | 6787 / 154040 (4.4%) | −130.4 | −128.5 | 0.22 |
| FOXA1 SRX1161205 | T-47D Breast | 180 / 15404 (1.2%) | 7427 / 154040 (4.8%) | −130.2 | −128.4 | 0.24 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 139 / 15404 (0.9%) | 6645 / 154040 (4.3%) | −130.2 | −128.3 | 0.21 |
| FOXA1 SRX5203303 | MCF-7 Breast | 108 / 15404 (0.7%) | 6023 / 154040 (3.9%) | −130.2 | −128.3 | 0.18 |
| ARID5B SRX10475138 | Hep G2 Liver | 595 / 15404 (3.9%) | 14029 / 154040 (9.1%) | −130.1 | −128.2 | 0.42 |
| GFP SRX5417098 | HeLa Uterus | 407 / 15404 (2.6%) | 11207 / 154040 (7.3%) | −129.9 | −128.0 | 0.36 |
| ESR1 SRX330068 | MCF-7 Breast | 154 / 15404 (1.0%) | 6920 / 154040 (4.5%) | −129.6 | −127.8 | 0.22 |
| FOXA1 SRX3931056 | MCF-7 Breast | 201 / 15404 (1.3%) | 7777 / 154040 (5.0%) | −129.3 | −127.5 | 0.26 |
| FOSL2 SRX190224 | MCF-7 Breast | 117 / 15404 (0.8%) | 6181 / 154040 (4.0%) | −129.1 | −127.3 | 0.19 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1655 / 15404 (10.7%) | 8403 / 154040 (5.5%) | −128.8 | −127.0 | 1.97 |
| FOXA1 SRX3923515 | MCF-7 Breast | 195 / 15404 (1.3%) | 7651 / 154040 (5.0%) | −128.7 | −126.8 | 0.25 |
| FOXA1 SRX1447316 | MCF-7 Breast | 144 / 15404 (0.9%) | 6698 / 154040 (4.3%) | −128.6 | −126.8 | 0.21 |
| AR SRX9109113 | MDA-MB-453 Breast | 692 / 15404 (4.5%) | 15353 / 154040 (10.0%) | −128.6 | −126.8 | 0.45 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 592 / 15404 (3.8%) | 13920 / 154040 (9.0%) | −128.5 | −126.7 | 0.43 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 197 / 15404 (1.3%) | 7674 / 154040 (5.0%) | −128.2 | −126.4 | 0.26 |
| DNA-RNA hybrid SRX20083264 | SH-SY5Y Neural | 655 / 15404 (4.3%) | 1962 / 154040 (1.3%) | −128.2 | −126.4 | 3.34 |
| STAT3 SRX2020847 | MDA-MB-468 Breast | 248 / 15404 (1.6%) | 8566 / 154040 (5.6%) | −128.1 | −126.3 | 0.29 |
| ATF3 SRX1384025 | HCT 116 Digestive tract | 210 / 15404 (1.4%) | 7901 / 154040 (5.1%) | −128.1 | −126.3 | 0.27 |
| JUND SRX092301 | K-562 Blood | 474 / 15404 (3.1%) | 12164 / 154040 (7.9%) | −128.0 | −126.2 | 0.39 |
| FOXA1 SRX3931032 | MCF-7 Breast | 201 / 15404 (1.3%) | 7737 / 154040 (5.0%) | −128.0 | −126.2 | 0.26 |
| FOXA1 SRX5323830 | T-47D Breast | 207 / 15404 (1.3%) | 7844 / 154040 (5.1%) | −128.0 | −126.1 | 0.26 |
| NR3C1 SRX19024870 | MCF-7 Breast | 108 / 15404 (0.7%) | 5960 / 154040 (3.9%) | −128.0 | −126.1 | 0.18 |
| EP300 SRX100544 | Hep G2 Liver | 266 / 15404 (1.7%) | 8859 / 154040 (5.8%) | −127.8 | −126.0 | 0.30 |
Showing first 500 of 17556 rows.